Emergent BioSolutions, Inc. (EBS) was a big mover last session, as its shares rose nearly 6% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company, as the stock is now trading above the volatile price range of $19.92 to $21.83 in the past one-month time frame.

In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Emergent BioSolutions currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%.

Other well-performing biomedical stocks include Halozyme Therapeutics, Inc. (HALO), Merrimack Pharmaceuticals, Inc. (MACK) and Exact Sciences Corporation (EXAS). All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>



MERRIMACK PHARMACEUTICALS INC (MACK): Free Stock Analysis Report

EMERGENT BIOSOLUTIONS INC (EBS): Free Stock Analysis Report

HALOZYME THERAPEUTICS INC (HALO): Free Stock Analysis Report

EXACT SCIENCES CP (EXAS): Free Stock Analysis Report


Zacks Investment Research